KING PHARMACEUTICALS INC
CIK 0001047699
Revenue (TTM)
$1.65B
Q3 Nov 2010
Net Income (TTM)
$137.63M
Q3 Nov 2010
EPS Diluted (TTM)
$0.55
Q3 Nov 2010
Gross Margin
—
Q3 Nov 2010
Operating Margin
16.6%
Q3 Nov 2010
Net Margin
8.3%
Q3 Nov 2010
Free Cash Flow (TTM)
—
Q3 Nov 2010
Cash
$697.52M
Q3 Nov 2010
Total Debt
$350.22M
Q3 Nov 2010
Shares Outstanding
249.97M sh
Q3 Nov 2010